National Institute of
General Medical Sciences

MIRA provides support for the research in an investigator's laboratory that falls within the mission of NIGMS. The goal of MIRA is to increase the efficiency of NIGMS funding by providing investigators with greater stability and flexibility, thereby enhancing scientific productivity and the chances for important breakthroughs. The program will also help distribute funding more widely among the nation's highly talented and promising investigators. MIRA grants will generally be for 5 years, for both established investigators and early stage investigators. With the publication of PAR-22-180 the program has now expanded to include established investigators who currently hold an NIGMS R01-equivalent grant or who wish to renew a MIRA; early stage investigators may apply through PAR-20-117.

MIRA Welcome Letter

PAR-22-180
Applications accepted in 2023 - 2025​FAQs About MIRA PAR-22-180MIRA Eligibility for Administrative Supplements

MIRA Current and Pending Support Model Attachment (Required) Flowchart for MIRA Eligibility Determination​

PAR-20-117
Applications accepted through October 3, 2022FAQs About ESI MIRA PAR-20-117Eligibility: NIH Definitions of Early Stage Investigators and Related Policies and ProceduresOther resources for ESI MIRA applicants

ESI MIRA Webinar Slides, August 2020ESI MIRA Webinar Video, August 2020MIRA Eligibility for Administrative Supplements

​For more information on MIRA for ESIs contact Sailaja Koduri, Ph.D.